PDGFRB and breast cancer: However, when BM‐MSCs were treated with a nuclease‐resistant RNA aptamer targeting PDGFRβ, the signaling pathways dependent on this receptor were inhibited, leading to a significant impairment in the homing of BM‐MSCs to breast cancer cells.98